FAP and breast cancer: Instead, we chose one syngeneic subcutaneous lung cancer LL/2 and one spontaneously occurring mammary cancer with frequent lung metastasis (MMTV-PyVT GEMM) and investigated the therapeutic and immune effects of FAP-targeted NIR-PIT.